, penetratin, also known as Ant16 (RQIKIWFQNRRMKWKK) [7, 8] and Ant7 (RRMKWKK) [7] , both derived from the homeodomain of the Drosophila melanogaster Antennapedia protein, or polyarginines like R9 [7, 9, 10] . Since their discovery in 1988 [3, 4], a broad range of bioactive molecules has been delivered by PTDs into cells both in vitro and in vivo [11]. This technology is thus considered to bear enormous potential to introduce macromolecular therapeutics into cells [12, 13] 
Introduction

The delivery of molecules through the plasma membrane into cells is a major technical obstacle for the development of diagnostic tools or therapeutic agents acting on intracellular targets. In many cases, molecules cannot penetrate cellular membranes due to their biophysical properties. This is especially true for peptides and proteins containing polar or even charged side chains. One way to achieve internalization is the fusion of cargos to ligands of cell-surface receptors. Following receptor-ligand interaction, the cargo is taken up into endosomal compartments by receptor-mediated endocytosis [1, 2]. After endosomal escape, the therapeutic agent, for instance, can inhibit a given target protein by blocking its active site. However, this method requires the covalent coupling of a ligand to the cargo which often leads to altered properties with respect to ligand affinity as well as to the activity of the cargo. Moreover, this targeted approach is highly restricted to certain cell types that express a certain cell-surface receptor and to the internalization properties of the targeted receptor. An alternative way to induce cell membrane permeability of the cargo is its linkage to protein transduction domains (PTDs), also known as cell penetrating peptides. A PTD is a short peptide comprising an amino acid sequence, which enables it to induce its own internalization into a variety of eukaryotic cell types. Examples of well-studied cationic PTDs are the Tat13 peptide of the HIV-1 trans-activator protein (YGRKKRRQRRRPP)
, penetratin, also known as Ant16 (RQIKIWFQNRRMKWKK) [7, 8] and Ant7 (RRMKWKK) [7] , both derived from the homeodomain of the Drosophila melanogaster Antennapedia protein, or polyarginines like R9 [7, 9, 10] . Since their discovery in 1988 [3, 4] , a broad range of bioactive molecules has been delivered by PTDs into cells both in vitro and in vivo [11] . This technology is thus considered to bear enormous potential to introduce macromolecular therapeutics into cells [12, 13] . Notably [14] [15] [16] . However, the genetic fusion of PTDs to cargos can result in reduced protein expression and purification levels [7] . Moreover, the genetic or chemical linkage of PTDs can impair the biophysical properties of the cargo [7] . Therefore [17] , were delivered into cells by PTD-biotin [18, 19] , on the basis of the high affinity of the SA/biotin interaction [20] . Vice versa, SA linked to the Tat-PTD was generated as a transporter for biotinylated proteins [21, 22] [23] .
As an alternative for polyhistidine/Ni-NTA, the Strep-tag II system has become very common for one-step purification of proteins or high-affinity detection [24] . [29] .
Thermal tetramer stability
SA and ST tetramerization [25] is required for building the binding pocket for biotin and Strep-tag II [30] . Both SA and ST tetramers are extremely stable, even in the presence of SDS, and therefore can be detected on SDS-PAGE [31, 32] Fig. 2(A) . Up to a temperature of 60ЊC, all proteins were detectable in a tetrameric state (Fig. 2B) . (Fig. 2) .
. Since instability of transporters can restrict their use, the influence of different PTD fusions on the temperature-dependent ST tetramer breakup was studied, as exemplified for Tat13-ST in
Unfused ST exhibited a slightly reduced tetrameric stability when compared to unfused SA (60ЊC versus 65ЊC). Notably, all PTD fusions slightly increased the tetramer stability of ST: Ant7-ST showed a tetramer stability of 65ЊC, Tat13-ST and R9-ST tetramers were stable up to 70ЊC (Fig. 2B). At further increased temperatures, the amount of tetramers started to decrease for all proteins, with concomitant appearance of monomeric forms
Secondary structure analysis
Since PTD fusions can influence the biophysical properties of cargos [7] , far UV CD spectroscopy was performed to assess possible alterations in the secondary structure of ST due to the N-terminal PTD-fusions. The spectra of all Transtactins showed an almost identical curve progression as unfused ST (Fig. 3A) , similar to the CD spectrum of SA. CD spectra were interpreted using PEPFIT [27] . The fractions of secondary structure were compared with the crystal structures of SA [33] and ST [34] (Fig. 3B) . Both the line shapes of the CD spectra and the PEPFIT data indicated that all proteins share similar ␤-sheet content of approximately 44.5% to 54% and ␣-helix rates up to 7% (Fig. 3B) . These minor differences can be explained by the N-terminal PTD-fusions or slight skewing of the analyses of CD spectra due to the need to compensate for the unusual pronounced positive peaks at 230 nm [35] (most likely one lobe of an exciton interaction between aromatic side chains [36, 37] (Fig. 4) . (Fig. 5A ). This pattern is consistent with previous reports investigating internalization of PTD-fused cargos which accumulated in the cytosol and in distinct perinuclear inclusions which were subsequently identified as endosomal compartments [21, 22] . [22] (Fig. 5B) , indicating that FITCStrep-tag II is enriched in endosomal compartments, consistent with previous findings for PTD-linked cargos [22, 38] . (Fig. 6A) [26] . The expression of Transtactins as inclusion bodies thus seems to prevent the common problems of both reduced expression levels and purification yields for PTD-fused cargos [7] [30] . High thermal tetramer stabilities were measured for all engineered Transtactin variants, as reported for SA [31, 32] [24] . Thirdly, unlike Strep-tag II [24] , biotinylation may disturb cargo functions due to the chemical linkage.
Internalization of PTD-ST
To investigate the ability of Transtactin proteins to internalize into mammalian cells, HeLa cells were incubated with different
PTD
MALDI-TOF MS
Intracellular distribution of internalized Transtactins
Transtactin-mediated co-internalization of FITC-Strep-tag II
In order to investigate whether Transtactins were able to co-internalize a small model molecule linked to Strep-tag II, HeLa cells were treated for 2 hrs with Tat13-ST or R9-ST complexed with FITC-Strep-tag II. We observed that FITC-Strep-tag II was clearly internalized by both Transtactins (Fig. 5B). In contrast, cells control-treated with FITC-Strep-tag II alone or FITC-Strep-tag II complexed with unfused ST exhibited only background FITC fluorescent signals (Fig. 5B). Staining pattern for FITC-Strep-tag II inside cells was punctual, indicating enrichment in distinct cellular compartments. These signals co-stained with the fluid-phase endosomal marker TRITC-dextran
Internalization of peptides, proteins and complexes by Transtactins
Transtactins also should have advantages over the introduction of cargos which are directly linked to a PTD. Firstly, PTDfused cargos often suffer from reduced expression and purification levels [7] in contrast to Strep-tag II-cargos prepared for internalization by Transtactins. Secondly, PTD-fused agents have been shown to penetrate intact skin [14] [15] [16] [7, 43] and non-cell permeable therapeutic peptides [44, 45] and proteins [46] [47] [48] . Moreover, it could be envisioned to develop Transtactins as transporters for therapeutically useful cargos in human beings. However, at present, this latter issue still faces technical hurdles associated with protein therapeutics in general which include proteolytic instability of PTDs [49] and antigenicity of SA [50] . Possible solutions to reduce the potential antigenicity of Transtactins include site-directed mutagenesis of solvent-exposed side chains, as shown for SA [51] , or replacement of ST by non-immunogenic scaffolds, like human-derived lipocalins [52, 53] 
